Article Information
History
- October 30, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Kate Zinszer, PhD1,2,*,
- Katia Charland, PhD2,
- Laura Pierce, MSc2,
- Adrien Saucier, BSc1,2,
- Britt McKinnon, PhD2,3,
- Marie-Ève Hamelin, PhD4,
- Islem Cheriet, BSc1,
- Margot Barbosa Da Torre, MPH1,2,
- Julie Carbonneau, MSc4,
- Cat Tuong Nguyen, MD5,
- Gaston De Serres, MD6,
- Jesse Papenburg, MD7,
- Guy Boivin, MD4 and
- Caroline Quach, MD1,8
- 1University of Montreal, Montreal, Quebec, Canada
- 2Centre for Public Health Research, University of Montreal, Quebec, Canada
- 3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
- 4Infectious Disease Research Center, Research Centre of Quebec-Université Laval, Quebec City, Quebec, Canada
- 5Ministère de la santé et des services sociaux, Quebec City, Quebec, Canada
- 6National Institute of Public Health of Quebec, Quebec City, Quebec, Canada
- 7Montreal Children’s Hospital of the McGill University Health Centre
- 8Research Centre of the Sainte-Justine University Hospital, Montreal, Quebec, Canada
- ↵*Corresponding Author: kate.zinszer{at}umontreal.ca, 514.679.2995, School of Public Health, University of Montreal, Montreal, Quebec, Canada
Posted October 30, 2022.
Seroprevalence, seroconversion, and seroreversion of infection-induced SARS-CoV-2 antibodies among a cohort of children and adolescents in Montreal, Canada
